# Atlast Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atlast-health

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.atlasthealth.co.jp/
- Total disclosed funding: $2.5M
- Latest round: Series A (Jun 13, 2024)
- Investors on record: 6

## About

Established in 2019 by Neal Baloch (CEO), and based in Tokyo, Japan, Atlast Health Inc., formerly known as FRoots Corporation, is a health tech company that uses technology and high resolution to provide healthcare and extend mental healthcare services. In June 2024, ATLAST HEALTH Inc. raised Series A funding from JAFCO Group, Hakuhodo DY Ventures, Norinchukin Capital, LITALICO, and Mental Health Technologies with participation from Dawn Capital.

Trust Health leverages technology to enhance psychiatric care, providing high-resolution, IT-driven medical services. Their offerings include an online consultation system that allows patients to book appointments, consult with psychiatrists, and handle prescriptions and payments entirely online. Additionally, Trust Health offers a cloud-based system for mental health clinics, digitizing key operations such as scheduling, pre-visit questionnaires, and cashless payments to improve efficiency and reduce patient burden.

The company intends to use the June 2024 funds to develop an online medical platform, implement marketing initiatives to boost awareness, and expand the personnel in its clinic digital experience business.

## Funding rounds

- Series A, Jun 13, 2024, $2.5M — JAFCO Group, Dawn Capital, Mental Health Technologies Co., Ltd., Hakuhodo DY Ventures, LITALICO, Norinchukin Capital

## Investors

- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A
- Dawn Capital (https://capitalatlas.ai/funds/dawn-capital) — Series A
- Mental Health Technologies Co., Ltd. — Series A
- Hakuhodo DY Ventures (https://capitalatlas.ai/funds/hakuhodo-dy-ventures) — Series A
- LITALICO — Series A
- Norinchukin Capital (https://capitalatlas.ai/funds/norinchukin-capital) — Series A
